Ampersand 2018 Limited Partnership - Oct 11, 2024 Form 4 Insider Report for INTERPACE BIOSCIENCES, INC. (IDXG)

Role
10%+ Owner
Signature
/s/ Dana L. Niles, Chief Operating Officer of AMCLLC
Stock symbol
IDXG
Transactions as of
Oct 11, 2024
Transactions value $
$0
Form type
4
Date filed
10/15/2024, 07:00 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXG Series B Convertible Preferred Stock Disposed to Issuer +28K 0 Oct 11, 2024 Common Stock 4.67M $6.00 See Footnotes F1, F2, F3, F4
transaction IDXG Series C Convertible Preferred Stock Award +28K 28K Oct 11, 2024 Common Stock 13.9M $2.02 See Footnotes F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Series B Convertible Preferred Stock, par value $0.01 per share, of the Issuer (the "Series B Preferred Shares") were convertible from time to time, at the option of the holder thereof, into a number of shares of common stock, par value $0.01 per share, of the Issuer (the "Common Stock"), equal to the initial stated value per Series B Preferred Share of $1,000 divided by a conversion price of $6.00 per share (the "Series B Conversion Price") and then multiplied by the number of Series B Preferred Shares to be converted. The Series B Preferred Shares had no expiration date.
F2 On October 11, 2024, the Issuer exchanged all 28,000 existing shares of Series B Shares held by Ampersand 2018 Limited Partnership (the "Investor") for 28,000 newly created shares of Series C Convertible Preferred Stock, par value $0.01 per share, of the Issuer (the "Series C Preferred Shares").
F3 These securities are held of record by the Investor. AMP-18 Management Company Limited Partnership ("AMCLP") is the general partner of the Investor, and AMP-18 MC LLC ("AMCLLC") is the general partner of AMCLP. By virtue of such relationships, AMCLP and AMCLLC may be deemed to have voting and investment power with respect to the securities held by the Investor noted above and as a result may be deemed to have beneficial ownership over such securities.
F4 Each of the Investor, AMCLP and AMCLLC disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
F5 The Series C Preferred Shares are convertible from time to time, at the option of the holder thereof, into a number of shares of Common Stock equal to the initial stated value per Series C Share of $1,000 divided by an initial conversion price of $2.02 per share and then multiplied by the number of Series C Preferred Shares to be converted. The Series C Preferred Shares have no expiration date.